Needham & Company Remains Bullish on Omeros (OMER) Following Mixed 3Q

November 10, 2016 7:04 AM EST
Get Alerts OMER Hot Sheet
Price: $10.05 -4.1%

Rating Summary:
    10 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 18 | New: 19
Trade OMER Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Needham & Company maintained a Buy rating on Omeros Corp. (NASDAQ: OMER), and cut the price target to $24.00 (from $28.00), following the company's 3Q earnings report. OMER met the topline expectations due to summer seasonality around Omidria, and met the Street's expectations on the bottom-line. 3Q Omidria sales were $11.3MM compared to the consensus of $15MM.

Analyst Serge Belanger commented, "OMER's 3Q16 results were mixed, missing on the topline due to summer seasonality around Omidria but meeting Street expectations on the bottom-line. A slowdown in cataract procedures over the summer months led to a slowdown in Omidria growth in 3Q16. Volumes have since reaccelerated in Sept/Oct recently pacing at a rate equivalent to $55MM in annualized Omidria sales. The next key event for OMER revolves around OMS721. We continue to await results from the ongoing ph 2 trial in aHUS. We also expect OMER to initiate an open-label ph 3 study of OMS721 in aHUS patients by YE16. The pipeline, while early, represents significant potential upside drivers, in our view. We continue to expect a ramp up in Omidria sales but we adjust our numbers for seasonal effects. We maintain our Buy rating and adjust our PT to $24 (from $28)."

For an analyst ratings summary and ratings history on Omeros Corp. click here. For more ratings news on Omeros Corp. click here.

Shares of Omeros Corp. closed at $10.13 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Needham & Company, Earnings

Add Your Comment